1. Home
  2. PCLA vs NCEL Comparison

PCLA vs NCEL Comparison

Compare PCLA & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$0.17

Market Cap

10.7M

ML Signal

HOLD

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.66

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PCLA
NCEL
Founded
2008
2008
Country
Japan
Switzerland
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
10.0M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
PCLA
NCEL
Price
$0.17
$2.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.1M
204.8K
Earning Date
02-13-2026
12-01-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,065,197.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.26
N/A
52 Week Low
$0.12
$1.89
52 Week High
$9.80
$7.64

Technical Indicators

Market Signals
Indicator
PCLA
NCEL
Relative Strength Index (RSI) 38.68 N/A
Support Level $0.19 N/A
Resistance Level $0.25 N/A
Average True Range (ATR) 0.03 0.00
MACD -0.01 0.00
Stochastic Oscillator 3.88 0.00

Price Performance

Historical Comparison
PCLA
NCEL

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: